Exagen
XGN
35 hedge funds and large institutions have $59.7M invested in Exagen in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
27% more capital invested
Capital invested by funds: $47M → $59.7M (+$12.8M)
1.62% more ownership
Funds ownership: 33.85% → 35.46% (+1.6%)
3% less funds holding
Funds holding: 36 → 35 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.42M |
| 2 |
EP
Eversept Partners
New York
|
+$1.15M |
| 3 |
BlackRock
New York
|
+$547K |
| 4 |
CAC
Cowen and Company
New York
|
+$328K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$357K |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$189K |
| 3 |
Squarepoint
New York
|
-$110K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$87.4K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
New York State Common Retirement Fund
Albany,
New York
| $61K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $51K | -$35.3K | -2,501 | -39% |
|
28
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $44K | +$13.3K | +944 | +39% |
|
|
29
Russell Investments Group
London,
United Kingdom
| $25K | -$357K | -25,289 | -93% |
|
30
Citigroup
New York
| $12K | +$9.69K | +686 | +298% |
|
31
UBS Group
Zurich,
Switzerland
| $11K | +$11.5K | +815 | +1,811% |
|
32
Legal & General Group
London,
United Kingdom
| $8K | – | – | – |
|
|
AIP
33
Ameritas Investment Partners
Lincoln,
Nebraska
| $4K | – | – | – |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$4.17K | +295 | +2,458% |
|
|
AIG
35
American International Group
New York
| $37 | -$1.12K | -79 | -3% |
|
|
36
Calamos Advisors
Naperville,
Illinois
| – | -$189K | -17,474 | Closed |
|
|
PCM
37
Prelude Capital Management
New York
| – | -$1K | -117 | Closed |
|
XGN Hedge Fund Activity: Q4 2020 in Review
35 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2020, worth a combined $59.7M — up 27% from $47M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of XGN and 1 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 15 added.
The largest buyer was Wasatch Advisors, adding an estimated $1.42M. The largest seller was Russell Investments Group, cutting an estimated $357K.
- 35 institutional investors held Exagen (XGN) as of Q4 2020, down from 36 in Q3 2020.
- Funds reported $59.7M of Exagen stock for Q4 2020, up 27% quarter-over-quarter.
- 1 fund opened new Exagen positions in Q4 2020 and 2 closed out, a net change of -1 holder.
- The largest Exagen buyer in Q4 2020 was Wasatch Advisors, an estimated $1.42M added.
- The largest Exagen seller in Q4 2020 was Russell Investments Group, an estimated $357K sold.
Based on aggregated 13F filings for Q4 2020.